In the current scenario, the prostate tumor is observed as a growing indolent tumor or advanced aggressive cancer however according to evidence the currently available diagnostic biomarker prostate-specific antigen (PSA) and histological examinations of tumor tissues cannot completely specify the tumor stages, as well as its aggressiveness (2). This evidence concerns the gene KLK3 and cancer.